Current treatment for heart automaticity disorders still lack a safe and efficient source of stem cells to bring about biological pacemaking. Since adult Muscle-Derived Stem Cells (MDSC) show multilineage differentiation in vitro including into spontaneously beating cardiomyocytes, we questioned whether MDSCs could effectively differentiate into cardiac pacemakers, a specific population of myocytes producing electrical impulses in the sino-atrial node of adult heart. We show here that beating cardiomyocytes, differentiated from MDSC in vitro, exhibit typical characteristics of cardiac pacemakers: the expression of Hcn4, Tbx3 and Islet1, as well as spontaneous calcium transients and hyperpolarization-activated "funny" current, a unique signature of sino-atrial pacemakers. Pacemaker-like myocytes differentiated in vitro from Cav1.3 -deficient mouse MDSC produced slower Ca 2+ transients, consistent with the reduction of native pacemaker activity in these mice. In vivo, systemic injection of undifferentiated wild type MDSCs into bradycardic mutant
Introduction
Stem cells with the capacity to self-renew and differentiate into several lineages can be isolated from most adult tissues and organs. However, as the largest vascularised and innervated organ in the body, and one with the life-long ability to undergo atrophy and regeneration, skeletal muscle is particularly rich in multipotent stem cells (reviewed by Peault et al., 1 and by Tamaki et al 2, 3 ). Various populations of stem cells were isolated from muscle, the best studied being satellite cells. Named from their tight association to muscle fibres, satellite cells account for muscle fibre regeneration and are an heterogeneous population (reviewed by Yin et al. 4 ). In addition skeletal muscle contains connective tissue-, vascularisation-, and innervation-derived progenitor and stem cells, which cooperate with satellite cells in tissue repair (reviewed by Peault et al. 1 , Tamaki et al. 3 and Ten Broek et al. 5 ). Consistent with the neuro-muscular identity of skeletal muscle, differentiation of muscle-derived stem cells into different meso-ectodermal cell lineages was reported in several studies including from human muscle [6] [7] [8] and after clonal growth of muscle stem cells 9 .
We previously reported that a population of muscle-derived stem cells (MDSCs) 10 isolated from adult mouse muscle on the basis of their low adherence by sequential preplating 11, 12 is multipotent 10 . In particular this population spontaneously differentiated into autonomously beating cardiomyocyte-like cells 10 . This autonomous phenotype questioned whether beating cardiomyocytes derived from MDSC may be identical to pacemaker myocytes, a small population of highly specialized cells in the right atrium of adult hearts located in the Sino-Atrial (SAN) and Atrio-Ventricular Node (AVN) 13 . Pacemaker cells are endowed with automatic electrical activity, and this enables them to generate the cardiac impulse that is conducted through the atrial tissue and the AVN, to the Purkinje fibre network from which it depolarizes the ventricular myocardium 13 . In vertebrates, automaticity is one of the first features of cardiogenesis, with all cardiac cells of the early embryo capable of autonomous beating. During late development of the chambers and conduction system, the SAN emerges from a morphologically distinct area that develops within the sinus venosus, at the site where the right atrium enters the intercaval region, due to up-regulation of the Tbx18 and Tbx3 transcription factors and their repression of cardiogenic Nkx2.5 14, 15 . The generation and conduction of the pacemaker impulse within the SAN differs from that in working atrial myocytes in that membrane depolarisation is spontaneous and intercellular electrical resistance is high 16, 17 . To fulfil this requirement, pacemaker myocytes uniquely express a particular set of ion channels: the hyperpolarisation-activated cAMP-gated cation channel 4, HCN4; voltagegated Cav1.3 channels; and a specific subset of connexins, including connexin45 (Cx45) and Cx30.2
(but not the high-conductance gap junction proteins Cx40 and Cx43 which are typically expressed in working cardiomyocytes) 18, 19 . Pacemaker myocytes thus represent a specialized cardiac myocyte type that is essential for proper heart function and whose properties and defining markers are distinct from those of working cardiomyocytes.
In humans, SAN dysfunction (SND) results in reduced life expectancy and necessitates the implantation of >450,000 pacemakers/year in Europe and the U.S., a number predicted to double over the next half century 20 . Whereas pacemaker implantation remains the primary therapy for SAN dysfunction and bradycardia-associated arrhythmias 21 , this approach is costly, requiring lifelong management including regular technical inspections. These limitations and complexity in the use of an electronic device are even greater in pediatric and young patients 22 . Considering the global impact of SAN dysfunction, it is generally agreed that new therapeutic strategies are needed.
The development of a cell-therapy approach to repair the damaged SAN and restore pacemaker activity is paramount to achieving stable, life-long improved heart function and to restoring patient quality of life 22 . Toward this goal it will be necessary to identify suitable sources of transplantable stem cells that are capable of differentiating, in vivo, into functional pacemaker myocytes.
In the current study, we tested the ability of MDSCs to differentiate, both in vitro and in vivo in mutant mice, into pacemaker myocytes. We report that MDSC can migrate and home to the SAN where they differentiate into pacemaker-like cardiomyocytes, and that this homing and differentiation of MDSCs ameliorates heart rhythm in congenitally bradycardic mutant mice.
Results

In vitro analysis: MDSCs spontaneously differentiate into autonomously beating
cardiomyocytes with the characteristics of pacemaker cells.
MDSCs were isolated from mouse hind-limb muscle via sequential preplating of non-adherent cells, as shown in Fig. 1a and described previously 10 . Non-adherent stem cells were replated in fresh proliferation medium every 24 hours to avoid their premature differentiation and to stimulate their proliferation. The rationale for daily replating and centrifugation is two-fold: the replating prevents loss of the less adherent stem cells, which would otherwise attach to counterparts that adhere and proliferate more rapidly (e.g., fibroblasts, myofibroblasts and pre-adipocytes); and the centrifugation depletes the cultures of muscle fibre-derived microsomes and other muscle-specific non-cellular components that may contribute to the myogenic commitment of muscle stem cells. A comparative analysis of the transcriptomes of muscle cells extracted 24 hours after activation of proliferation (corresponding to PP1) and MDSCs isolated after 7 days of pre-plating (corresponding to PP8) revealed a 12-fold increase in cyclinA2 expression (Fig.1b) , indicating a high level of cell proliferation. The same analysis revealed a 10-fold increase in the expression of Islet-1, a LIMhomeodomain transcription factor expressed in heart and pancreatic progenitor/stem cells, and a >30-fold increase in expression of Peg3/PW1, which is expressed in stem cells isolated from muscle and several adult tissues 23 . Of note, the stemness factor Nestin, whose expression is high even in PP1 cells, was increased >2-fold in PP8 MDSCs (Fig. 1b) . These data confirm that 7 days of preplating non-adherent cells from mouse skeletal muscle is an effective means of isolating a proliferating stem cell population.
We previously reported that non-adherent MDSCs in PP8 cultures provided with an attachment matrix such as laminin, fibronectin, or a fibroblast layer (but not collagen) became adherent and underwent multi-lineage differentiation 10 . Amongst the different phenotypes observed, cells with the ability to beat autonomously were observed within 3 to 5 days and these cells exhibited persistent contractile activity for over 2 months in culture ( Fig.1c 27 .
A hallmark of cardiac pacemaker cells is their expression of the channel HCN4 28 , which is responsible for generating the "funny" current (If) 29 . RT-PCR analysis of pacemaker-like MDSCPMs (Fig. 2b , Table S1) showed that they express the pore-forming subunits of HCN4 and Cav1.3 channels, both of which are required for normal cardiac pacemaker activity in mice [30] [31] [32] [33] [34] and humans 35, 36 . MDSC-PMs also express the pacemaker-specific gap junction protein Cx45 14,37 and the cardiac contractile proteins -actinin and Troponin I (Fig. 2b) . The co-expression of these proteins in beating pacemaker-like cells was tested by double-immunofluorescence of cultured, differentiated MDSCs, with cells undergoing sustained beating filmed before fixation. Fig. 2c shows immunostaining of MDSC-PMs for HCN4 and Cav1.3. Given that HCN proteins, Cav1.3, and Cx45 are also markers of neural cells, co-staining for cytoskeletal markers of striated muscle cells (cardiac Troponin I or sarcomeric -actinin) was necessary to confirm the cardiac phenotype (Fig.2c) . Of note, in the panels showing co-staining for -actinin and Cx45, a typical neural cell on the right expressed Cx45 but not -actinin. We next tested MDSC-PMs for the functional properties of native sino-atrial pacemaker using current-clamp recordings (Fig. 3 34, 40, 41 . Line-scan images were recorded before and after the cultures were perfused with epinephrine or acetylcholine, to determine whether the frequency of spontaneous Ca 2+ i transients was regulated in opposite directions by the activation of -adrenergic 34 and muscarinic 42 receptors.
Indeed, epinephrine (2 nM, Fig. 3d ) accelerated, whereas acetylcholine (50 nM, Fig. 3d ) reduced, the frequency of spontaneous Ca 2+ i transients. Ryanodine receptors (RyRs) are also involved in sino-atrial pacemaker activity (reviewed in ref. 43 ) and perfusion of MSDC-PMs with ryanodine (3 M, Fig. 3d ) led to a near-complete arrest of spontaneous Ca 2+ i transients. Thus, RyRs appear to play a major role in the automaticity of MDSC-PMs, similar to that in native SAN pacemakers 43 .
We previously showed that loss of Cav1.3 channels slows automaticity and leads to arrhythmia in native SAN myocytes 30, 34 chemotactic axis, a major pathway in the regulation of stem-cell migration and homing 51, 52 . Indeed, comparison of the expression of SDF1 and CXCR4 levels in SAN tissue isolated from the two groups of mice showed that SAN tissue from Cav1.3 -/-mice expressed higher levels of both SDF1
and CXCR4 than did SAN tissue from wild-type counterparts (RT-PCR analysis in Supplementary   Fig. 4 ).
To determine whether SAN engraftment of injected wild type MDSC was followed by their differentiation into cardiac myocytes, we isolated intact SAN tissue from the hearts of Cav1.3 -/-mice 30 to 40 days after MDSC injection and performed whole-mount immunostaining for cells expressing the Cav1.3 pore-forming 1 subunit, which is absent from SAN tissue originating from the recipient mutant mouse 44, 53 . As shown Fig.5 , the SAN of transplanted Cav1.3 -/-mice was positive for Cav1.3 staining. Notably, arrays of cells (zoomed panels 5a and 5c with 49 and 54
Cav1.3 -expressing cells, respectively) showed membrane and striated patterns of staining for Cav1.3 similar to those for native mouse SAN pacemaker cells 53 , including increased staining at junctions between cells with typical pacemaker morphology (arrow in Fig. 5b ). Fig. 5 ). Staining for Cav1.3 was specific because it was absent in the SAN of control mock-transplanted Cav1.3 -/-mice (n=5, Supplementary Fig. 6 ).
Whether colonization of the SAN by MDSCs and their differentiation in bradycardic mutant mice was accompanied by an improvement in heart rhythm was determined by analyzing heart rate during the resting (daylight) period. To this end, telemetric ECG recordings were made in freely moving Cav1.3 -/-mice, before and at different times after the injection of undifferentiated wild-type MDSCs (Fig. 6a) . Consistent with a previous study 44 , Cav1.3 -/-mice experienced SAN dysfunction and atrioventricular blocks before injection, (Fig. 6a and Table 1 ). However, by 40 days after systemic transplantation of muscle-derived stem cells, the MDSC-injected mice had a significantly higher (32%, Fig. 6b ) heart rate than before the procedure ( Fig. 6b and Table 1 ), indicating that the SAN pacemaker activity had improved. Heart rate elevation in Cav1.3 -/-mice was due to improvement of SAN rate (PP interval). No significant differences were observed in heart rate and the other ECG parameters in wild-type mice. Similarly, no significant changes in heart rate were observed following implantation of only a ECG transmitter (no MDSCs; Supplementary Fig. 7a ) or when control wild-type mice were injected with MDSCs ( MDSCs. This recording of sedated mice revealed a significant increase in heart rate in the doublemutant mice by 10 days (+28%, Supplementary Fig. 7b ) and a decrease in the inter beat standard deviation after 20 days ( Supplementary Fig. 7c ), whereas similar injection of MDSCs into wild-type mice did not result in significant changes in either heart rate or inter beat standard deviation ( Supplementary Fig. 7b-c) . The number of SAN pauses or AV blocks after MDSC injection into either single Cav1.3 -/-or double Cav1.3 -/-/Cav3.1 -/-mutants did not change significantly (Table 1 and 2). Together these data show that systemic injection of wild-type MDSCs into bradycardic mutant mice resulted in a significant improvement in the heart rate of mutant mice whereas it did not affect the heart rate of wild-type mice. Although transplantation of a similar population of MDSCs has been reported to improve recovery of the heart from ischemic injury, the effect in that case was attributed to the secretion of paracrine factors without significant retrieval or differentiation of donor stem cells 58 . ESCs and iPSCs can differentiate into beating, pacemaker-like cells in vitro 46, 47 . These differentiated cells were recently shown to be able to engraft in the ventricle and support pacemaker activity 48, 49 . However, their transforming and teratoma-forming potential precludes their direct use for cell therapy and requires prior cueing toward cardiac differentiation, with a potential loss of plasticity, migration and survival ability 46, 59 . In contrast, MDSCs, which are non-tumorigenic, were directly transplanted into the bloodstream or peritoneal space of mutant recipient mice, where they not only homed to the SAN and differentiated into beating, pacemaker-like cells, but also reduced defects in heart automaticity that are associated with the knock-out of the Cav1.3 Ca 2+ channel 44 . Importantly, we also show here that MDSCs can differentiate in vitro into spontaneously active MDSC-PMs, displaying features of mature SAN pacemaker cells. This also make MDSCs a convenient source of stem cells to recapitulate defects in heart automaticity ex vivo and assay potential therapeutic drugs.
Discussion
In SAN cells, heart automaticity is generated by an association between the activity of ion channels such as Cav1.3 30 , HCN4 38 and that of RyR-dependent Ca 2+ release from the sarcoplasmic reticulum 43 . Genetic ablation (from muscle-donor mouse) or pharmacologic inhibition of these channel activities in spontaneously active MDSC-PMs reproduced slowing of pacemaker activity, as reported in the current literature on native SAN-resident pacemaker cells. Our results thus indicate that the pacemaker mechanism underlying spontaneous activity of MDSC-PMs is similar to that of native SAN, and support the notion that MDSCs differentiated in vitro from mutant mice can reproduce and model heart-rhythm dysfunctions. This hypothesis is in line with the capability of MDSCs to improve the heart rate of mutant mice following their colonization of the SAN and differentiation at this site.
Although the mechanism underlying the spontaneous ability of MDSCs to migrate and home to the SAN tissue of mutant mice is not fully understood, it likely involves chemotaxis via the SDF1-CXCR4 pathway, as supported by data shown in Supplementary Fig. 4 . Furthermore, in light of reports on heart regeneration by exercise-activated cardiac stem cells 60 , on the activation of muscle stem cells by exercise (review by Macaluso & Myburgh 61 ), and on the presence of stem cells from recipient patients in transplanted human hearts (i.e., "chimeric transplanted hearts") 62, 63 , it is tempting to speculate that some stem cells that have been classified as "resident cardiac" may have originated from exercise-activated circulating MDSCs. It is known that denervation, like exercise, results in long-lasting activation and proliferation of resident muscle stem cells but that 90% of these cells are subsequently lost from the muscle (and not fused to the denervated-reinnervated muscle) 64 . In this regard, it will be important to compare profiles of circulating stem cells retrieved after exercise or muscle denervation to those in the resting state.
We recently showed that the MDSCs studied here migrate and home to streptozotocindamaged pancreatic islets 48 hours after I.P. injection and that within 10 days they differentiate into cells expressing insulin 50 . Further, we found that MDSCs are recruited to site(s) of injury, be it chemically induced 50 or mechanically induced (such as glycerol injection in one of the two tibialis muscles) (Davaze, Mitutsova et al., manuscript in preparation). Thus, the capability of MDSCs to migrate and home to damaged tissues could be exploited for therapeutic purposes.
SAN dysfunction is a multi-factorial disease that often begins with a moderate reduction in heart rate that is otherwise asymptomatic, and that this subsequently degenerates into bradycardia associated with invalidating symptoms and syncope 65 . Early therapy of SAN dysfunction could potentially avoid or delay the need to implant an electronic pacemaker 20 . In this regard, restoring damaged or degenerated SAN tissue by direct transplantation of MDSCs, in particular from the own muscle of the patient, constitutes an attractive possibility. We found that amelioration of heart rate in bradycardic mice occurs about 3 weeks following cell transplantation. This delay presumably reflects the time required for MDSCs to differentiate into MDSC-PMs. However, we recently also showed that the inhibition of G-protein gated K + channels (IKACh) (by either genetic deletion or a pharmacologic agent) may rescue the SAN dysfunction and heart block normally observed in
Cav1.3 -/-mice 42 . It is thus possible that future therapies for SAN dysfunction may combine a pharmacologic strategy such as IKACh inhibtion to improve heart rate in the short term, followed by a long-term cell therapy-based approach employing MDSCs.
Materials and Methods
Mouse strains
Six to ten week-old wild-type C57Bl/6 mice or transgenic C57Bl/6 "green mice" expressing eGFP under beta-actin promoter 66 were used to prepare MDSC as donor mice for transplantation experiments. Recipient wild-type, Cav1.3 -/-and Cav1.3 -/-/Cav3.1 -/-mice used for transplantation experiments were all of C57Bl/6 genetic background 54 . All procedures were performed in accordance with the animal care guidelines of the European Union, French laws and the Ethical committee of the University of Montpellier (N°: 2017010310594939).
Cell culture
MDSC were prepared using the preplate procedure originally described by Qu-Petersen et al. 11 as modified in Arsic et al. 10 Briefly, mouse hind-limb muscles were removed, minced and enzymatically dissociated at 37°C for Mouse adult fibroblast (MAF) were obtained from ATCC (Ltk-11) and grown as recommended by the supplier. Mouse ESCs were grown and harvested as described 67 .
Immunofluorescence analysis
Immunofluorescence analysis was performed on 2-6 week-cultured differentiated MDSC obtained from serial preplates as described 10 . Cells were fixed with 3.7% formaldehyde for 5 min, 
RNA isolation and reverse transcription polymerase chain reaction
Total RNA was extracted from sino-atrial node tissue, ventricular tissue, ESCs, mouse adult fibroblasts, MDSC and in vitro cultured differentiated MDSC using RNeasy kit (Qiagen) and then treated with RQ1 DNase treatement (Promega) according to the manufacturer's recommendations.
Ventricular and sino-atrial node tissues were obtained from 7-week-old C57Bl/6 adult male mice.
Total RNA was used to synthesize cDNA using the Superscript III reverse transcriptase kit DiI-CM (C7000 at 1µg/ml, ThermoFisher Scientific) according to the manufacturer's instruction.
Immunohistochemistry
Sino-atrial node tissue was dissected and fixed in 4% formaldehyde for 20 min before washing in PBS. After permeabilization in -20°C acetone, the whole SAN tissue was rehydrated with PBS. Non-specific binding of antibodies was blocked by incubation for 1h at room temperature with blocking solution (10% goat serum (Abcam), 0.1% Triton X-100 in PBS)
followed by incubation with Mouse Ig Blocking Reagent (Vector Laboratories) for 30 min.
Permeabilized and blocked sino-atrial tissue was then incubated overnight at 4°C with primary polyclonal anti-Cav1.3-1 subunit antibodies (prepared as described in ref. 53 ,1:500) diluted in 1% goat serum in PBS. Alexa488 or 555 fluorochrome goat anti-rabbit secondary antibodies (1:100, InVitrogen) in 1% goat serum were applied for 30 min at 37°C with Hoechst33358 nuclear stain (0.1 g/ml) for 40 min at 37°C. Autofluorescence was quenched by incubating in 1% Sudan Black B (Sigma-Aldrich) in 70% ethanol for 10 min before washing in 70% ethanol for 5 min at room temperature. Tissues were mounted with AirVol mounting medium before photomicroscopy as described in Arsic et al. 10 . The specificity of Cav1.3 staining was confirmed by its absence in sinoatrial tissue prepared from non-injected Cav1.3 -/-mice.
Measurements of contraction frequency
Cellular contraction of differentiated MDSC-PM was measured by an edge-detection IonOptix system device (LLC, 309 Hillside Street, Milton, MA 02186, USA). Cells were grown in 35 mm dishes in complete medium and analysed on an Olympus IX71 inverted microscope.
MDSC-PM were imaged at 120 Hz using an IonOptix™ Myocam-S CCD camera. Digitized images were displayed within the IonWizard™ acquisition software (IonOptix™). To measure changes in cell length, two cursors were placed at opposing edges of the cell defined as difference in optical density (maximum: dark; minimum: light). The relative movement of cursors assessed cell shortening. Experiments were performed at 36 °C.
Electrophysiological recordings of beating MDSC-PM, differentiated from MDSC in vitro
For electrophysiological recordings, aliquots of the cell suspension were harvested in 
Microscope and video imaging system
Digital images were collected using Leica DM LB microscope and Canon EOS300D digital camera as described before 10 . Videos of contracting cells were recorded using a NIKON D90 camera coupled to a Zeiss Axiovert 35M. A Nanozoomer Hamamatsu blade scanner was used for 2D reconstruction of whole mount SAN tissue (in Fig. S5 and Fig. S6 ).
Tumour formation assay 
ECG recordings and analysis in sedated mice
One-lead surface ECG measurements were recorded from wild-type and Cav1.3 -/-/Cav3.1 -/-mice sedated with 1.5% isofluorane. Body temperature was continuously maintained at 36° -37°C using a heated pad connected to a controller that received feedback from a temperature sensor attached to the mouse. Ag/AgCl gel-coated ECG electrodes (Unomedical) were attached to the superior right and both inferior limbs of mice. The electrodes were connected to a standard one-lead ECG amplifier module (EMKA Technologies, Paris, France), which included high-and low-pass filters (set to 0.05 Hz and 500 Hz, respectively) and a gain selection device (set to 1,000-fold).
Signals were digitized continuously at 2 kHz and recorded using an IOX data acquisition system (EMKA Technologies, France). The recordings were carried out for a 45-min period before (day 0) and at different days after transplantation (day 10 and day 20). The software ecgAuto (EMKA Technologies, France) was used to perform offline analysis of the data recorded. For each mouse the mean heart rate value and the Standard Deviation (SD) were calculated. Beat-to-beat analysis of heart rate was carried out on a 30-min interval taken 10 min after the beginning of each 45-min recording.
Telemetric recordings of ECG and analysis
For telemetric ECG recording, adult wild-type and Cav1.3 -/-male mice were anesthetized with 2% isofluorane. A midline incision was made on the back along the spine to insert a telemetric transmitter (TA10EA-F20, Data Sciences International) into a subcutaneous pocket with paired wire electrodes placed over the thorax (chest bipolar ECG lead). Local anaesthesia was obtained with lidocaine (1%) injected subcutaneously at the sites of electrodes and transmitter implantation.
To manage possible post-surgery pain, Advil (paracetamol and ibuprofene, 7 mL/l) was added to the drinking water for four days after implantation. Mice were housed in individual cages with free access to food and water and were exposed to 24-hour light/dark cycles (light 
Statistical analysis
The statistical significance of measured differences in heart rates or cellular rates of contraction was -/-mice are slower than those in their wild-type counterparts. Means are given ± S.E.M. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001 Table 1 ), before and up to 40 days after systemic transplantation of MDSCs. Data are presented as mean ± S.E.M. *p<0.05; **p<0.01; c. Quantitation of in vivo telemetric heart rate recordings in Cav1.3 -/-/Cav3.1 -/-double mutant mice before and after systemic transplantation of MDSCs (I.P. injection). d. Quantitation of heart rate recorded in Cav1.3 -/-/Cav3.1 -/-mice before (day 0) and on day 30 after I.P. transplantation of MDSCs from wild-type mice. nd -degree atrioventricular blocks (AVBII), (mean ± S.E.M.).
